Aslan Abazhidze (Author), Vladislav Malichenko (Author)

Abstract

A significant role in providing access to medicines is rightfully played by legal norms regulating intellectual property protection. The pharmaceutical sector stands out among other industries in terms of implementation of various mechanisms of intellectual property rights protection, which guarantee the possibility to recover economic losses due to tremendous investments in R&D. However, intellectual property protection mechanisms trigger the rise of medication costs, which significantly influence state expenditures and limit patient's access to treatment. At the time of scientific achievements access to medicines is directly linked with the right "to enjoy the benefits of scientific progress and its applications". It means that initiatives implemented by international organizations and national healthcare policies should contain balanced approach between the interests of the society and pharmaceutical producers in order to protect public and private interests.

Keywords

farmacija;zdravila;intelektualna lastnina;patenti;Ruska federacija;

Data

Language: English
Year of publishing:
Typology: 0 - Not set
Organization: UM PF - Faculty of Law
UDC: 347.77:615(470)
COBISS: 30003203 Link will open in a new window
ISSN: 1855-7147
Parent publication: Lexonomica
Views: 105
Downloads: 7
Average score: 0 (0 votes)
Metadata: JSON JSON-RDF JSON-LD TURTLE N-TRIPLES XML RDFA MICRODATA DC-XML DC-RDF RDF

Other data

Secondary language: English
Secondary keywords: farmacija;zdravila;intelektualna lastnina;patenti;Ruska federacija;
Pages: str. 1-14
Volume: ǂVol. ǂ11
Issue: ǂno. ǂ1
Chronology: June 2019
DOI: 10.18690/lexonomica.11.1.1-14.2019
ID: 12388698
Recommended works:
, no subtitle data available
, smernice za izumitelje
, praktični vodič za raziskovalce in pisarne za prenos znanja in tehnologij
, zaključna strokovna naloga visoke poslovne šole
, diplomsko delo